We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
-$63.6M
Cap. Flow
-$14.6M
Cap. Flow %
-1.4%
Top 10 Hldgs %
44.54%
Holding
900
New
268
Increased
133
Reduced
141
Closed
310

Top Buys

Rank Stock Value
1
SLVM icon
Sylvamo
SLVM
+$64.9M
2
ARKK icon
ARK Innovation ETF
ARKK
+$54.7M
3
FULC icon
Fulcrum Therapeutics
FULC
+$48.9M
4
RIVN icon
Rivian
RIVN
+$32.4M
5
STOK icon
Stoke Therapeutics
STOK
+$22.5M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$143M
2
IPOF
Social Capital Hedosophia Holdings Corp. VI
IPOF
+$49M
3
CCVI
Churchill Capital Corp VI
CCVI
+$34.2M
4
AMD icon
Advanced Micro Devices
AMD
+$27.5M
5
CLDX icon
Celldex Therapeutics
CLDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Financials 15.44%
3 Materials 6.54%
4 Consumer Discretionary 6.02%
5 Industrials 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PIAI.WS
301
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$74K 0.01%
315,139
+300,973
+2,125% +$114K
MSDAW
302
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$72K 0.01%
+92,517
New +$79.3K
KCGI.WS
303
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$72K 0.01%
119,614
+94,614
+378% +$62.6K
ALNY icon
304
Alnylam Pharmaceuticals
ALNY
$29.6B
$71K 0.01%
+436
New +$66.4K
ALNY icon
305
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
$70K 0.01%
+10,500
New +$1.6M
C icon
306
CALL
Citigroup
C
$228B
$66K 0.01%
67,400
+30,000
+80% +$1.85M
SNAXW
307
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$66K 0.01%
447,066
+400,987
+870% +$121K
KAHC.WS
308
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$66K 0.01%
100,000
– –
AUS.WS
309
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$66K 0.01%
120,000
+70,000
+140% +$44.6K
AFRM icon
310
CALL
Affirm
AFRM
$25.7B
$65K 0.01%
+20,000
New +$1.05M
POND.WS
311
DELISTED
Angel Pond Holdings Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
POND.WS
$63K 0.01%
+92,739
New +$57.5K
APLS
312
DELISTED
Apellis Pharmaceuticals
APLS
$62K 0.01%
+1,230
New +$54.3K
ATVI
313
CALL
DELISTED
Activision Blizzard
ATVI
$61K 0.01%
+102,700
New +$8M
CNGLW
314
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$60K 0.01%
+425,524
New +$73.3K
IFIN.WS
315
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$60K 0.01%
+351,904
New +$75.9K
FTCVW
316
DELISTED
FinTech Acquisition Corp. V Warrant
FTCVW
$60K 0.01%
+63,558
New +$64.4K
VSACW
317
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$58K 0.01%
+275,256
New +$74.6K
ZNGA
318
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$58K 0.01%
+307,800
New +$2.7M
DCRDW
319
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
$57K 0.01%
+98,785
New +$65.9K
PETS icon
320
PUT
PetMed Express
PETS
$42.3M
$56K 0.01%
+10,200
New +$265K
WPCA.WS
321
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$56K 0.01%
+119,214
New +$91.2K
APLS
322
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$55K 0.01%
+4,200
New +$185K
VRM icon
323
PUT
Vroom Inc
VRM
$51.5M
$54K 0.01%
+1,081
New +$513K
TALKW
324
DELISTED
Talkspace Inc Warrant
TALKW
$53K 0.01%
222,235
-27,765
-11% -$5.92K
VGASW icon
325
Verde Clean Fuels Warrant
VGASW
$739K
$53K 0.01%
279,369
+204,369
+272% +$54.5K
11 12
13
14 15

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2022 Portfolio in Review

As of Q1 2022, Cowen and Company held 900 positions worth $1.04B, down 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Cowen and Company's Q1 2022 filing shows 268 new, 133 increased, 141 reduced and 310 closed positions. Its largest new stake was Sylvamo: 1,955,000 shares worth $65.1M. The largest sale was Invesco QQQ Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 26% a quarter earlier, followed by Financials and Materials.

  • Cowen and Company's largest Q1 2022 buy was Sylvamo: 1,955,000 shares worth $65.1M.
  • Cowen and Company added most to ARK Innovation ETF in Q1 2022, an estimated $54.7M increase.
  • Cowen and Company's biggest Q1 2022 reduction was Invesco QQQ Trust, cutting an estimated $143M.
  • Cowen and Company fully exited Churchill Capital Corp VI in Q1 2022, selling an estimated $34.2M.
  • Cowen and Company's ten largest holdings make up 45% of its $1.04B portfolio in Q1 2022.
  • Cowen and Company opened 268 new positions and closed 310 in Q1 2022.
  • Cowen and Company's portfolio value fell 5.8% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.